Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nexosome Oncology Logo
Nexosome Oncology Growth Score
42
CB Rank
94356
Heat Score
69
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.
Founded
obfuscation
PrivateSeed Lexington, Kentucky, United States11-50 nexosome-oncology.com/
Health Care
Health Diagnostics
Oncology
Overview

Nexosome Oncology
Total Funding
obfuscation
Growth Score
42
Heat Score
69

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score42
1 pts
in past quarter
Heat Score 69
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Nexosome Oncology

CB Rank
94356
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.
Founded
obfuscation
PrivateSeed Lexington, Kentucky, United States11-50 nexosome-oncology.com/
Health Care
Health Diagnostics
Oncology

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Nexosome Oncology Holdings, In
Operating Status Active
Company Type For Profit
About the Company
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Extracellular Vesicle (EV) Isolation and Liquid Biopsy Platform
A proprietary technology for isolating extracellular vesicles from plasma to enable liquid biopsy-based cancer detection and biomarker discovery.
Proteomic Biomarker Discovery Workflow
A machine learning-driven process that identifies multiplex protein biomarkers from EV plasma subfractions for cancer detection and staging.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed
obfuscation
Seed Round - Nexosome Oncology Logo
Seed Round - Nexosome Oncology
3
obfuscation
OCA VenturesSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jan 10, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

152

IT Spend

$86KThis year, Nexosome Oncology is projected to spend $86K on IT, according to Aberdeen.

Active Website Tech Count

9Nexosome Oncology is actively using 9 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.
Sub-Organizations
Frequently Asked Questions

Where is Nexosome Oncology's headquarters? Nexosome Oncology is located in Lexington, Kentucky, United States.Who invested in Nexosome Oncology? Nexosome Oncology has 3 investors including OCA Ventures and  Keyhorse Capital.When was the last funding round for Nexosome Oncology? Nexosome Oncology closed its last funding round on
obfuscation
from a Seed round.Who are Nexosome Oncology's competitors? Alternatives and possible competitors to Nexosome Oncology may include Grail, Freenome, and  Natera.How much funding has Nexosome Oncology raised to date? Nexosome Oncology has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|